Medicare Enrolled

Dr. Jirayos Chintanadilok, M.D.

Internal Medicine · Marianna, FL
Low-engagement
4296 5TH AVENUE, Marianna, FL 32446
8504822061
In practice since 2005 (20 years)
NPI: 1073516274 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chintanadilok from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chintanadilok? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chintanadilok

Dr. Jirayos Chintanadilok is an internal medicine specialist in Marianna, FL, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Chintanadilok received a total of $5,791 from 30 pharmaceutical and/or device companies across 369 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chintanadilok is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice $5,791 industry payments

Industry Payment Transparency

Open Payments through 2022 ↗
$5,791
Total received (2018-2022)
Avg $1,158/year across 5 years
Top 12% in FL for internal medicine
30
Companies
369
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,791 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2022
$247
2021
$1,265
2020
$1,078
2019
$1,308
2018
$1,893

Payments by company (2022)

Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$967
GlaxoSmithKline, LLC.
$951
Grifols USA, LLC
$868
Kowa Pharmaceuticals America, Inc.
$262
Novartis Pharmaceuticals Corporation
$258
AstraZeneca Pharmaceuticals LP
$253
Novo Nordisk Inc
$244
Lilly USA, LLC
$189
Philips Electronics North America Corporation
$185
Merck Sharp & Dohme Corporation
$163
Mylan Specialty L.P.
$161
Allergan Inc.
$161
Sunovion Pharmaceuticals Inc.
$147
SANOFI-AVENTIS U.S. LLC
$146
Inari Medical, Inc.
$139
Janssen Pharmaceuticals, Inc
$102
Electromed, Inc.
$97
PFIZER INC.
$83
Amgen Inc.
$81
JAZZ PHARMACEUTICALS INC.
$76
DEXCOM, INC.
$60
Actelion Pharmaceuticals US, Inc.
$38
Amarin Pharma Inc.
$30
Harmony Biosciences LLC
$26
Gilead Sciences, Inc.
$20
Eisai Inc.
$18
Inogen, Inc.
$17
Fisher & Paykel Healthcare Inc
$17
Bayer HealthCare Pharmaceuticals Inc.
$17
Strongbridge US INC.
$15
Top 3 companies account for 48.1% of total payments
Associated products mentioned in payments ›
(8207) DreamStation Cpap Core · (8361) DreamWisp · (8874) inCourage · ANORO · ANORO ELLIPTA · ASMANEX · AVYCAZ · BASAGLAR · BEVESPI AEROSPHERE · BREO · BREZTRI AEROSPHERE · CHANTIX · DALVANCE · DEXCOM G6 TRANSMITTER · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FASENRA · FLOWTRIEVER CATHETER · FORTEO · InogenOne · JANUVIA · JARDIANCE · KEVEYIS · Kerendia · LINZESS · LONHALA MAGNAIR · LYRICA · Livalo · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · Ozempic · Perforomist · Prolastin-C · Prolastin-C Liquid · Prolia · S · SMARTVEST · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · TEFLARO · TEZSPIRE · TOUJEO · TRELEGY ELLIPTA · TRULICITY · Trilogy 100 · UTIBRON · Utibron · Vascepa · Victoza · Wakix · XARELTO · Yupelri · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an internal medicine specialist in Marianna?
Compare internal medicine physicians in the Marianna area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
69
Per 100K population
144.8
County median income
$47,327
Nearest hospital
JACKSON HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2022
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Chintanadilok is an internal medicine specialist, with low-engagement industry engagement in the top 12% of FL peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Chintanadilok receive payments from pharmaceutical companies?
Yes. Dr. Chintanadilok received a total of $5,791 from 30 companies across 369 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Chintanadilok) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →